bioAffinity Technologies Appoints New Science Team

PUBLISHED ON April 4, 2016

SAN ANTONIO, TX (April 4, 2016) bioAffinity Technologies, a privately held cancer diagnostics company, today announced that Vivienne Rebel, M.D., Ph.D., has joined the Company as Executive Vice President of Research and Development (R&D) and Chief Medical and Science Officer.

read more